Sls Health Inc is categorized under Operators of Nonresidential Buildings in Brewster, NY and active since 1984.
Sls Health Inc was established in 1984, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Operators of Nonresidential Buildings business, which does work in the B2B market, and is classified as a Operators of Nonresidential Buildings, under code number 531312 by the NAICS.
If you are seeking more information, feel free to contact Joseph Santoro at the company’s single location by writing to 2503 Carmel Avenue Department 279, Brewster, New York NY 10509 or by phoning (845) 279-5994. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sls Health Inc |
| Contact Person: | Joseph Santoro |
| Address: | 2503 Carmel Avenue Department 279, Brewster, New York 10509 |
| Phone Number: | (845) 279-5994 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1984 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Operators of Nonresidential Buildings |
| SIC Code: | 6512 |
| NAICS Code: | 531312 |
| Share This Business: |
Sls Health Inc was started in 1984 to provide professional Operators of Nonresidential Buildings under the SIC code 6512 and NAICS code 531312. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Santoro for inquiries that concern Sls Health Inc by calling the company number (845) 279-5994, as your correspondence is most welcome. Additionally, the physical location of the single location of Sls Health Inc can be found at the coordinates as well as the street address 2503 Carmel Avenue Department 279 in Brewster, New York 10509.
For its online presence, you may visit Sls Health Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.